Sickle Cell Disease
Existing Patients
Make an appointment by phone
617.638.6428
Make an appointment with MyChart
Book with MyChart
Hours of Operation: Monday-Friday 8:00 AM - 4:00 PM
New Patients
If you are a new patient and need an appointment, please contact us at the phone number below.
Learn more about coming to BMC. 617.638.6428Please Note:
For appointments with the Adult Clinic, please contact: 617.638.6428
For appointments with the Pediatric Clinic, please contact: 617.414.4841
Refer a Patient
Refer a patient
Call for assistance with the referral process
617.638.6428
For referrals to the Adult Clinic, please contact: 617.638.6428
For referrals to the Pediatric Clinic, please contact: 617.414.4841
Hours of Operation: Monday-Friday 8:00 AM - 4:00 PM
BMC’s Center of Excellence in Sickle Cell Disease is the largest center of its kind in New England, serving more than 450 patients annually, from newborns to adults. The center’s multidisciplinary team is committed to providing patients across their lifespan with highly personalized care to manage their symptoms associated with the disease so they can live as normal a life as possible.
The SCD team includes physicians and a nurse practitioner from pediatric and adult hematology, adult and pediatric primary care, and other specialties as well as nurses, social workers, case management and a patient navigator to help guide patients through their care. The program focuses on providing consistent care between the Emergency Department, inpatient services, and outpatient clinics. The program utilizes the pediatric STAR unit and the Infusion Center in the adult Hematology/Oncology clinic for outpatient transfusions and pain management.
Features of the Center
- Largest combined SCD pediatric and adult population within one center in New England
- Studying how sickle cell disease affects the body and investigating new potential treatments
- Expertise in the transition of care from pediatrics to adulthood
- Expertise in management of the complications of SCD with medical and surgical specialists who treat our patients
- Expertise in pain management
- Continued development of new initiatives to improve patient care
Contact Us
Adult Clinic
3rd Floor
Moakley Building 617.638.6428
Pediatric Clinic
6th Floor
Yawkey Center 617.414.4841
Specialty Clinics
Hematology
Patients with blood disorders receive consultation and treatment for a broad range of benign conditions, such as hemoglobinopathies (sickle cell anemia and thalassemia), hemochromatosis, bleeding and thrombotic disorders (von Willebrand's disease and hemophilia), hypercoagulable states, myeloproliferative disorders, myelodysplasia and anemia, and malignancies such as leukemia, lymphoma and myeloma.
Pediatrics - Hematology
Conditions We Treat
Our Team
Jean-Antoine Ribeil, MD, PHD
Special Interests
Hemoglobinopathies, Red Blood Cell Disorders
Elizabeth S Klings, MD
Amy E Sobota, MD, MPH
Santia Berberena, PsyD
Special Interests
adult mental health, bariatric medicine, health psychology and stress management techniques, interventions in clinical hypnosis, trauma informed interventions and care, Latino and Afro-Caribbean mental health, immigrant mental health, Native American mental health, cognitive and personality assessment
Robyn T Cohen, MD
Terrell Y Johnson, MD
Lillian E McMahon, MD
Special Interests
Sickle Cell Disease, Sickle Cell Anemia, Hemoglobin C Disease, Hemoglobinopathies
Caitlin M Neri, MD
Melisa Ruiz-Gutierrez MD
Martin H Steinberg, MD
Charlene M Sylvestre, NP, MSN, MSW, RN, NP-C, CCAP
Special Interests
Sickle Cell Disease
Darryl A Woods, MD
Additional Information
Department News
Meet BMC’s Clinical Director for the Center of Excellence in Sickle Cell Disease
Jean-Antoine Ribeil, MD, PhD, recently joined Boston Medical Center’s Department of Hematology and Oncology as clinical director of the Center of Excellence in Sickle Cell Disease. As an…
Athletes gearing up for Boston Triathlon on July 24
Athletes across the city are pumping up their tires and lacing up their shoes for the Boston…
Research Overview
BMC researchers are finding innovative new ways to treat and cure blood disorders.
As our patient, you'll have access to a wide range of clinical trials from both BMC researchers and researchers at other institutions. While we enroll any and all eligible patients in clinical trials, BMC physicians are in particular leaders in the enrollment of under-represented minorities in clinical trials.
Learn more about clinical trials for Sickle Cell Disease at BMC.
Affiliations
Latest from HealthCity
'A Cure Affordable for All': What Drives Jason and Devin McCourty's Sickle Cell Disease Advocacy
Inspired by their Aunt Winnie, the McCourty twins have made a cure for sickle cell disease a driving force of their life's work off the football field
Mandatory Reporting Law Is Harmful for Pregnant People with SUD
BMC experts testified in support of eliminating the requirement to report abuse and neglect for babies born with neonatal opioid withdrawal syndrome.
New Strategies Aim to Improve Sickle Cell Disease Care
Progress toward improving outcomes for adults with sickle cell disease hinges on more qualified, trained physicians and investment in research.
Why Are Therapeutics Lagging for Sickle Cell Disease?
Structural racism has neglected advancements in SCD treatment. Novel therapies are on the horizon, but can they affordably be brought to the masses?
Reducing Care Fragmentation in Sickle Cell Disease
Comprehensive, multidisciplinary services that provide whole-person care can be difficult to find. Experts are changing that.
COVID-19, Sickle Cell Disease, and a Critical Need
Respiratory viruses are known to cause severe complications in people with sickle cell disease, many of whom already face significant challenges.
Shifting the Culture of SDOH Screening in Specialty Clinics
Research from a sickle cell disease clinic hopes to shift the philosophy of subspecialty clinics to embrace a more holistic view of patient health.
Telementoring Bridges the Gap in Sickle Cell Disease Care
Medical communities are improving treatment access for pediatric sickle cell disease by crowdsourcing expertise among clinicians.
Our Clinic Was Struggling With No-Shows. So We Called an Uber.
A pilot program suggests ride-hailing services are an effective, low-cost solution for patients with transportation barriers.
